Search clinical trials for: Enzalutamide, Abiraterone
Total 552 results
-
AstraZenecaParexelCompleted
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Active, not recruiting
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Cedars-Sinai Medical CenterCompletedProstate CancerUnited States
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
PfizerAstellas Pharma IncActive, not recruitingProstatic NeoplasmsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteDendreonRecruitingProstate Cancer | Metastatic Prostate CancerUnited States
-
The Netherlands Cancer InstituteCompletedMetastasis | Prostate Cancer MetastaticNetherlands
-
PfizerAstellas Pharma IncActive, not recruiting
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Australia, Spain, United Kingdom, Denmark, Belgium, Slovakia, Finland, Italy, France, Sweden
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
AmgenRecruitingProstate CancerJapan, United States, Korea, Republic of, Taiwan, Australia, Spain, Germany, Switzerland, Portugal, China
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
PfizerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
PfizerAstellas Pharma IncActive, not recruitingProstatic Neoplasms, Castration-ResistantUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Pharmacokinetics of EnzalutamideUnited States
-
British Columbia Cancer AgencyCompletedMetastatic Castration-Resistant Prostate CancerCanada
-
Duke UniversityCompleted
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityRecruitingCastration-resistant Prostate CancerChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
Leiden University Medical CenterAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Anticancer...RecruitingProstatic Neoplasms, Castration-ResistantAustralia, Netherlands
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States, Spain, Australia, United Kingdom
-
Radboud University Medical CenterActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Groupe Hospitalier Pitie-SalpetriereCompletedEpilepsy | Prostate Cancer | Neuropathy | EncephalopathyFrance
-
zr Pharma & GmbHCompletedMetastatic Castration Resistant Prostate CancerUnited States
-
James J. Peters Veterans Affairs Medical CenterNot yet recruitingMetastatic Cancer | Neoplasm, ProstateUnited States
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaboratorsTerminated
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Macquarie University, AustraliaUnknown
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Janssen Research & Development, LLCCompleted
-
Fundación Canaria de Investigación SanitariaHospital Universitario de CanariasUnknown
-
Radboud University Medical CenterCompletedProstate CancerNetherlands
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingProstate Cancer Castration-resistant Prostate CancerChina
-
University of HawaiiTerminated
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Castration-resistent Prostate CancerItaly
-
Alessa Therapeutics Inc.National Cancer Institute (NCI)Not yet recruitingProstate AdenocarcinomaUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Grupo Español de Tumores Huérfanos e InfrecuentesAstellas Pharma Inc; Apices Soluciones S.L.Completed
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownMetastatic Castrate-resistant Prostate (CRPC) CancerFrance